Source: International Journal of Infectious Diseases. Unidade: FMRP
Subjects: CÉLULAS EPITELIAIS, INTESTINOS, CITOCINAS, INFLAMAÇÃO, COVID-19, INTERLEUCINA 6
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAIA, Rafael Simone et al. Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection. International Journal of Infectious Diseases, v. 113, p. 82-86, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ijid.2021.09.051. Acesso em: 29 set. 2024.APA
Saia, R. S., Giusti, H., Silva, F. L. da, Pedroso, K. de J. B., Martins, M. A., Morejón, K. M. L., et al. (2021). Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection. International Journal of Infectious Diseases, 113, 82-86. doi:10.1016/j.ijid.2021.09.051NLM
Saia RS, Giusti H, Silva FL da, Pedroso K de JB, Martins MA, Morejón KML, Degiovani AM, Cadelca MR, Basile-Filho A. Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection [Internet]. International Journal of Infectious Diseases. 2021 ; 113 82-86.[citado 2024 set. 29 ] Available from: https://doi.org/10.1016/j.ijid.2021.09.051Vancouver
Saia RS, Giusti H, Silva FL da, Pedroso K de JB, Martins MA, Morejón KML, Degiovani AM, Cadelca MR, Basile-Filho A. Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection [Internet]. International Journal of Infectious Diseases. 2021 ; 113 82-86.[citado 2024 set. 29 ] Available from: https://doi.org/10.1016/j.ijid.2021.09.051